Promising clinical trials surrounding Retatrutide , specifically the 120mg formulation branded as ZPHC, indicate a significant effect on physique loss and linked metabolic factors. Experts believe that this innovative compound, affecting both GLP-1 and GIP systems, has the potential to represent a noteworthy improvement in the treatment of obesity